

Myhep 400mg Tablet (Sofosbuvir (400 mg))
Manufactured By
Mylan pharmaceuticals
Pack Of
28
Salt Composition
Sofosbuvir (400 mg)
Storage
Keep in cold place
Overview
Myhep 400mg Tablet is an antiviral medicine that contains Sofosbuvir (400 mg) as an active ingredient. Doctor prescribes this tablet to treat chronic hepatitis C virus (HCV) infection. It works by reducing the viral load in the body and eliminate virus from the blood over time. It should be taken in dose and duration as advice by the doctor. Don't take more than recommend dose.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | myhep |
| Generic / Active Ingredient | Sofosbuvir |
| Strength | 400 |
| Dosage Form | Tablet |
| Manufacturer / Marketer | mylan pharmaceuticals |
| Pack Size | 28 |
| Prescription Required | Yes |
| Therapeutic Categories | Hepatitis Medicines |
| Uses | hepatitis |
Uses and Indications
Hepatitis C
Side Effects of Myhep 400mg Tablet
Every medicine has some side effects that manage on their own as your body gets used to the medicine, but some people may rarely experience severe side effects. In that case, the patient should contact the doctor immediately.
Some common side effects of Myhep 400mg Tablet(Sofosbuvir 400mg) include:
● Fatigue
● Nausea
● Headache
● Insomnia (difficulty sleeping)
● Anemia (low number of red blood cells)
Myhep 400mg Tablet Dosage and How To Take It
Take Myhep 400mg Tablet in dosage as prescribed by the doctor. Dosage and the duration determined as per the patients health condition. This tablet should be swallowed as a whole with water. Don't crush, chew, or break the tablet. It should be taken with food. Never skip a dose or double dose.
Safety Advice for Myhep 400mg Tablet
- ● Alcohol: Avoid the consumption of alcohol while taking Myhep 400mg Tablet(Sofosbuvir 400mg), as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms
- ● Pregnancy: Myhep 400mg Tablet is safe to use during pregnancy, if prescribed by the doctor. No dosage adjustment is necessary for this tablet as limited data is available that shows significant risk.
- ● Breastfeeding: Myhep 400mg Tablet(Sofosbuvir 400mg) is safe to use while breastfeeding, if prescribed by the doctor. No dosage adjustment is necessary for this tablet as limited data is available that shows significant risk.
- ● Driving: Myhep 400mg Tablet(Sofosbuvir 400mg) may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.
- ● Kidney: Share your medical history with the doctor before starting the Myhep 400mg Tablet. Do not take it without consulting a doctor if you have any kidney related issue.
- ● Liver: Myhep 400mg Tablet(Sofosbuvir 400mg) is safe for use in liver disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.
FAQs About Myhep 400mg Tablet
Is it safe to take the Myhep 400mg Tablet(Sofosbuvir 400mg) during pregnancy or breastfeeding?
Consumption of Myhep 400mg Tablet during pregnancy or breastfeeding is considered to be safe if prescribed by the doctor.
What types of diseases are treatable with Myhep 400mg Tablet?
Myhep 400mg Tablet prescribed to the patients with chronic hepatitis C virus (HCV) infection.
What are the common side effects of Myhep 400mg Tablet(Sofosbuvir 400mg)?
There are some common yet manageable side effects of taking Myhep 400mg Tablet that include tiredness and headache.
Can a patient with liver related issue take Myhep 400mg Tablet?
Yes, it is safe to take Myhep 400mg Tablet(Sofosbuvir 400mg) in liver related conditions if prescribed by the doctor.
Can I drive after taking Myhep 400mg Tablet?
It is unsafe to drive after taking treatment with this medicine as lack of concentration or dizziness is the common side effect of Myhep 400mg Tablet(Sofosbuvir 400mg).
References
● Bhatia, H. K., Singh, H., Grewal, N., & Natt, N. K. (2014). Sofosbuvir: A novel treatment option for chronic hepatitis C infection. Journal of pharmacology and pharmacotherapeutics, 5(4), 278-284.
● Keating, G. M. (2014). Sofosbuvir: a review of its use in patients with chronic hepatitis C. Drugs, 74(10), 1127-1146.
● Cada, D. J., Cong, J., & Baker, D. E. (2014). Sofosbuvir. Hospital Pharmacy, 49(5), 466-478.
● Nazario, H. E., Ndungu, M., & Modi, A. A. (2016). Sofosbuvir and simeprevir in hepatitis C genotype 1‐patients with end‐stage renal disease on haemodialysis or GFR< 30 ml/min. Liver International, 36(6), 798-801.
● Asselah, T. (2014). Sofosbuvir for the treatment of hepatitis C virus. Expert opinion on pharmacotherapy, 15(1), 121-130.
Marketer Details
Mylan pharmaceuticals
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.


